"A groundbreaking case report details a phenomenon previously associated with severe poisoning: urine glowing a vivid, visible fluorescent yellow, not from a black light, but from a new stomach acid…
New research indicates that direct warnings about depression and anxiety are more impactful in discouraging social media use among teens and young adults than generic time-out reminders, though actual behavioral…
"A groundbreaking laboratory model of the human bladder has revealed why some urinary tract infections stubbornly return, even after antibiotic treatment, by demonstrating that bacteria can hide in protected reservoirs…
"The FDA’s swift action to bolster the supply of essential intravenous nutrition for vulnerable newborns underscores a critical shift towards preemptive crisis management in pharmaceutical supply chains, safeguarding the most…
"Consumers are urged to immediately stop using two popular male enhancement supplements, Business Pill and Branch Manager for Men, as they have been found to contain dangerously high levels of…
"A proactive supplier test, not a single illness report, has triggered a nationwide recall of Foods Alive organic moringa leaf powder, highlighting a crucial shift in food safety detection where…
"This landmark FDA approval ushers in a new era of cancer treatment, shifting the decision to initiate therapy from radiographic evidence of progression to the molecular detection of resistance via…
"Nearly three-quarters of American adults report experiencing significant tiredness, with the youngest demographic — those aged 18 to 34 — surprisingly leading the nation in frequent fatigue, a stark contrast…
"A once-promising prevention strategy for sexually transmitted infections has shown a dramatic decline in its effectiveness against gonorrhea in Southern California, shifting from significant protection to a near-zero, and even…
"Etentamig demonstrates a remarkable 74% response rate in heavily pretreated multiple myeloma patients, significantly outperforming standard care and offering a potential paradigm shift in accessibility for advanced disease." AbbVie has…
